Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects
Phase 2
Recruiting
- Conditions
- Cholestatic Liver InjuryDrug-Induced Liver InjuryMixed Liver Injury
- Interventions
- Drug: MT2004 CapsuleDrug: MT2004 Capsule Placebo
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- Xi'An Aolitai Pharmaceutical Technology Co Ltd
- Target Recruit Count
- 80
- Registration Number
- NCT06019936
- Locations
- 🇨🇳
Shanghai Jiaotong University School of Medicine,Renji Hospital, Shanghai, Shanghai, China
News
No news found